nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—bone cancer	0.869	1	CbGaD
Trisalicylate-choline—PTGS2—Cisplatin—bone cancer	0.0928	1	CbGbCtD
Trisalicylate-choline—Magnesium salicylate—PTGS2—bone cancer	0.00199	0.54	CrCbGaD
Trisalicylate-choline—Salsalate—PTGS2—bone cancer	0.00169	0.46	CrCbGaD
Trisalicylate-choline—Hearing impaired—Cisplatin—bone cancer	0.00081	0.0239	CcSEcCtD
Trisalicylate-choline—Pain—Carboplatin—bone cancer	0.000802	0.0237	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Cisplatin—bone cancer	0.000736	0.0217	CcSEcCtD
Trisalicylate-choline—Body temperature decreased—Epirubicin—bone cancer	0.000706	0.0209	CcSEcCtD
Trisalicylate-choline—Hypothermia—Epirubicin—bone cancer	0.000706	0.0209	CcSEcCtD
Trisalicylate-choline—Gastric ulcer—Epirubicin—bone cancer	0.000681	0.0201	CcSEcCtD
Trisalicylate-choline—Body temperature decreased—Doxorubicin—bone cancer	0.000653	0.0193	CcSEcCtD
Trisalicylate-choline—Hypothermia—Doxorubicin—bone cancer	0.000653	0.0193	CcSEcCtD
Trisalicylate-choline—Gastric ulcer—Doxorubicin—bone cancer	0.00063	0.0186	CcSEcCtD
Trisalicylate-choline—Deafness—Cisplatin—bone cancer	0.000626	0.0185	CcSEcCtD
Trisalicylate-choline—Burning sensation—Methotrexate—bone cancer	0.000609	0.018	CcSEcCtD
Trisalicylate-choline—Burning sensation—Epirubicin—bone cancer	0.00057	0.0168	CcSEcCtD
Trisalicylate-choline—Stupor—Methotrexate—bone cancer	0.000567	0.0167	CcSEcCtD
Trisalicylate-choline—Burning sensation—Doxorubicin—bone cancer	0.000527	0.0156	CcSEcCtD
Trisalicylate-choline—Stinging—Epirubicin—bone cancer	0.000489	0.0144	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Cisplatin—bone cancer	0.000464	0.0137	CcSEcCtD
Trisalicylate-choline—Stinging—Doxorubicin—bone cancer	0.000452	0.0134	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Epirubicin—bone cancer	0.000432	0.0128	CcSEcCtD
Trisalicylate-choline—Depressed level of consciousness—Methotrexate—bone cancer	0.000408	0.0121	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Methotrexate—bone cancer	0.000404	0.0119	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Doxorubicin—bone cancer	0.0004	0.0118	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Epirubicin—bone cancer	0.000394	0.0116	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Methotrexate—bone cancer	0.000382	0.0113	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Epirubicin—bone cancer	0.000378	0.0112	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Doxorubicin—bone cancer	0.000364	0.0108	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Epirubicin—bone cancer	0.000362	0.0107	CcSEcCtD
Trisalicylate-choline—Tinnitus—Cisplatin—bone cancer	0.000361	0.0107	CcSEcCtD
Trisalicylate-choline—Flushing—Cisplatin—bone cancer	0.000359	0.0106	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Epirubicin—bone cancer	0.000358	0.0106	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Doxorubicin—bone cancer	0.00035	0.0103	CcSEcCtD
Trisalicylate-choline—Erythema—Cisplatin—bone cancer	0.000337	0.00995	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Doxorubicin—bone cancer	0.000335	0.00989	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Doxorubicin—bone cancer	0.000331	0.00978	CcSEcCtD
Trisalicylate-choline—Lethargy—Methotrexate—bone cancer	0.000313	0.00926	CcSEcCtD
Trisalicylate-choline—Lethargy—Epirubicin—bone cancer	0.000293	0.00866	CcSEcCtD
Trisalicylate-choline—Oedema—Cisplatin—bone cancer	0.000275	0.00812	CcSEcCtD
Trisalicylate-choline—Lethargy—Doxorubicin—bone cancer	0.000271	0.00801	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Cisplatin—bone cancer	0.000266	0.00785	CcSEcCtD
Trisalicylate-choline—Asthma—Methotrexate—bone cancer	0.000265	0.00784	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Epirubicin—bone cancer	0.000262	0.00775	CcSEcCtD
Trisalicylate-choline—Anorexia—Cisplatin—bone cancer	0.000262	0.00774	CcSEcCtD
Trisalicylate-choline—Hypotension—Cisplatin—bone cancer	0.000257	0.00759	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Methotrexate—bone cancer	0.000254	0.00752	CcSEcCtD
Trisalicylate-choline—Asthma—Epirubicin—bone cancer	0.000248	0.00734	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Doxorubicin—bone cancer	0.000243	0.00717	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Cisplatin—bone cancer	0.000239	0.00706	CcSEcCtD
Trisalicylate-choline—Drowsiness—Methotrexate—bone cancer	0.000237	0.00699	CcSEcCtD
Trisalicylate-choline—Pain—Cisplatin—bone cancer	0.000235	0.00695	CcSEcCtD
Trisalicylate-choline—Asthma—Doxorubicin—bone cancer	0.00023	0.00679	CcSEcCtD
Trisalicylate-choline—Sweating—Methotrexate—bone cancer	0.000227	0.0067	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Cisplatin—bone cancer	0.000227	0.00669	CcSEcCtD
Trisalicylate-choline—Weight increased—Epirubicin—bone cancer	0.000226	0.00668	CcSEcCtD
Trisalicylate-choline—Epistaxis—Methotrexate—bone cancer	0.000223	0.00659	CcSEcCtD
Trisalicylate-choline—Drowsiness—Epirubicin—bone cancer	0.000221	0.00654	CcSEcCtD
Trisalicylate-choline—Hepatitis—Methotrexate—bone cancer	0.000212	0.00627	CcSEcCtD
Trisalicylate-choline—Sweating—Epirubicin—bone cancer	0.000212	0.00627	CcSEcCtD
Trisalicylate-choline—Weight increased—Doxorubicin—bone cancer	0.000209	0.00618	CcSEcCtD
Trisalicylate-choline—Epistaxis—Epirubicin—bone cancer	0.000209	0.00617	CcSEcCtD
Trisalicylate-choline—Drowsiness—Doxorubicin—bone cancer	0.000205	0.00605	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Methotrexate—bone cancer	0.000201	0.00593	CcSEcCtD
Trisalicylate-choline—Hepatitis—Epirubicin—bone cancer	0.000199	0.00587	CcSEcCtD
Trisalicylate-choline—Tinnitus—Methotrexate—bone cancer	0.000198	0.00585	CcSEcCtD
Trisalicylate-choline—Sweating—Doxorubicin—bone cancer	0.000196	0.0058	CcSEcCtD
Trisalicylate-choline—Epistaxis—Doxorubicin—bone cancer	0.000193	0.00571	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Cisplatin—bone cancer	0.000188	0.00556	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Epirubicin—bone cancer	0.000188	0.00555	CcSEcCtD
Trisalicylate-choline—Tinnitus—Epirubicin—bone cancer	0.000185	0.00547	CcSEcCtD
Trisalicylate-choline—Erythema—Methotrexate—bone cancer	0.000185	0.00546	CcSEcCtD
Trisalicylate-choline—Flushing—Epirubicin—bone cancer	0.000184	0.00545	CcSEcCtD
Trisalicylate-choline—Hepatitis—Doxorubicin—bone cancer	0.000184	0.00543	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Methotrexate—bone cancer	0.000181	0.00535	CcSEcCtD
Trisalicylate-choline—Vomiting—Cisplatin—bone cancer	0.000175	0.00517	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Doxorubicin—bone cancer	0.000174	0.00514	CcSEcCtD
Trisalicylate-choline—Rash—Cisplatin—bone cancer	0.000173	0.00512	CcSEcCtD
Trisalicylate-choline—Dermatitis—Cisplatin—bone cancer	0.000173	0.00512	CcSEcCtD
Trisalicylate-choline—Erythema—Epirubicin—bone cancer	0.000173	0.00511	CcSEcCtD
Trisalicylate-choline—Tinnitus—Doxorubicin—bone cancer	0.000171	0.00507	CcSEcCtD
Trisalicylate-choline—Flushing—Doxorubicin—bone cancer	0.000171	0.00504	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Epirubicin—bone cancer	0.000169	0.00501	CcSEcCtD
Trisalicylate-choline—Nausea—Cisplatin—bone cancer	0.000163	0.00483	CcSEcCtD
Trisalicylate-choline—Erythema—Doxorubicin—bone cancer	0.00016	0.00473	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Doxorubicin—bone cancer	0.000157	0.00463	CcSEcCtD
Trisalicylate-choline—Confusional state—Methotrexate—bone cancer	0.000152	0.0045	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Methotrexate—bone cancer	0.000146	0.00431	CcSEcCtD
Trisalicylate-choline—Anorexia—Methotrexate—bone cancer	0.000144	0.00425	CcSEcCtD
Trisalicylate-choline—Confusional state—Epirubicin—bone cancer	0.000142	0.00421	CcSEcCtD
Trisalicylate-choline—Oedema—Epirubicin—bone cancer	0.000141	0.00417	CcSEcCtD
Trisalicylate-choline—Hypotension—Methotrexate—bone cancer	0.000141	0.00417	CcSEcCtD
Trisalicylate-choline—Shock—Epirubicin—bone cancer	0.000139	0.0041	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Epirubicin—bone cancer	0.000137	0.00403	CcSEcCtD
Trisalicylate-choline—Anorexia—Epirubicin—bone cancer	0.000135	0.00398	CcSEcCtD
Trisalicylate-choline—Somnolence—Methotrexate—bone cancer	0.000134	0.00396	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Methotrexate—bone cancer	0.000133	0.00392	CcSEcCtD
Trisalicylate-choline—Hypotension—Epirubicin—bone cancer	0.000132	0.0039	CcSEcCtD
Trisalicylate-choline—Confusional state—Doxorubicin—bone cancer	0.000132	0.00389	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Methotrexate—bone cancer	0.000131	0.00388	CcSEcCtD
Trisalicylate-choline—Oedema—Doxorubicin—bone cancer	0.000131	0.00386	CcSEcCtD
Trisalicylate-choline—Pain—Methotrexate—bone cancer	0.000129	0.00381	CcSEcCtD
Trisalicylate-choline—Shock—Doxorubicin—bone cancer	0.000129	0.0038	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Doxorubicin—bone cancer	0.000126	0.00373	CcSEcCtD
Trisalicylate-choline—Somnolence—Epirubicin—bone cancer	0.000126	0.00371	CcSEcCtD
Trisalicylate-choline—Anorexia—Doxorubicin—bone cancer	0.000125	0.00368	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Methotrexate—bone cancer	0.000124	0.00367	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Epirubicin—bone cancer	0.000124	0.00367	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Epirubicin—bone cancer	0.000123	0.00363	CcSEcCtD
Trisalicylate-choline—Hypotension—Doxorubicin—bone cancer	0.000122	0.00361	CcSEcCtD
Trisalicylate-choline—Constipation—Epirubicin—bone cancer	0.000121	0.00357	CcSEcCtD
Trisalicylate-choline—Pain—Epirubicin—bone cancer	0.000121	0.00357	CcSEcCtD
Trisalicylate-choline—Urticaria—Methotrexate—bone cancer	0.00012	0.00354	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Epirubicin—bone cancer	0.000116	0.00344	CcSEcCtD
Trisalicylate-choline—Somnolence—Doxorubicin—bone cancer	0.000116	0.00343	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Doxorubicin—bone cancer	0.000115	0.0034	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Doxorubicin—bone cancer	0.000114	0.00336	CcSEcCtD
Trisalicylate-choline—Urticaria—Epirubicin—bone cancer	0.000112	0.00331	CcSEcCtD
Trisalicylate-choline—Constipation—Doxorubicin—bone cancer	0.000112	0.0033	CcSEcCtD
Trisalicylate-choline—Pain—Doxorubicin—bone cancer	0.000112	0.0033	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Doxorubicin—bone cancer	0.000108	0.00318	CcSEcCtD
Trisalicylate-choline—Pruritus—Methotrexate—bone cancer	0.000107	0.00315	CcSEcCtD
Trisalicylate-choline—Urticaria—Doxorubicin—bone cancer	0.000104	0.00307	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Methotrexate—bone cancer	0.000103	0.00305	CcSEcCtD
Trisalicylate-choline—PTGS2—periosteum—bone cancer	0.000102	0.209	CbGeAlD
Trisalicylate-choline—Pruritus—Epirubicin—bone cancer	9.99e-05	0.00295	CcSEcCtD
Trisalicylate-choline—Dizziness—Methotrexate—bone cancer	9.98e-05	0.00295	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Epirubicin—bone cancer	9.66e-05	0.00285	CcSEcCtD
Trisalicylate-choline—Vomiting—Methotrexate—bone cancer	9.6e-05	0.00283	CcSEcCtD
Trisalicylate-choline—Rash—Methotrexate—bone cancer	9.52e-05	0.00281	CcSEcCtD
Trisalicylate-choline—Dermatitis—Methotrexate—bone cancer	9.51e-05	0.00281	CcSEcCtD
Trisalicylate-choline—Headache—Methotrexate—bone cancer	9.45e-05	0.00279	CcSEcCtD
Trisalicylate-choline—Dizziness—Epirubicin—bone cancer	9.34e-05	0.00276	CcSEcCtD
Trisalicylate-choline—Pruritus—Doxorubicin—bone cancer	9.25e-05	0.00273	CcSEcCtD
Trisalicylate-choline—Vomiting—Epirubicin—bone cancer	8.98e-05	0.00265	CcSEcCtD
Trisalicylate-choline—Nausea—Methotrexate—bone cancer	8.96e-05	0.00265	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Doxorubicin—bone cancer	8.94e-05	0.00264	CcSEcCtD
Trisalicylate-choline—Rash—Epirubicin—bone cancer	8.9e-05	0.00263	CcSEcCtD
Trisalicylate-choline—Dermatitis—Epirubicin—bone cancer	8.9e-05	0.00263	CcSEcCtD
Trisalicylate-choline—Headache—Epirubicin—bone cancer	8.85e-05	0.00261	CcSEcCtD
Trisalicylate-choline—Dizziness—Doxorubicin—bone cancer	8.64e-05	0.00255	CcSEcCtD
Trisalicylate-choline—Nausea—Epirubicin—bone cancer	8.39e-05	0.00248	CcSEcCtD
Trisalicylate-choline—Vomiting—Doxorubicin—bone cancer	8.31e-05	0.00245	CcSEcCtD
Trisalicylate-choline—Rash—Doxorubicin—bone cancer	8.24e-05	0.00243	CcSEcCtD
Trisalicylate-choline—Dermatitis—Doxorubicin—bone cancer	8.23e-05	0.00243	CcSEcCtD
Trisalicylate-choline—Headache—Doxorubicin—bone cancer	8.19e-05	0.00242	CcSEcCtD
Trisalicylate-choline—PTGS2—leg—bone cancer	8.13e-05	0.167	CbGeAlD
Trisalicylate-choline—Nausea—Doxorubicin—bone cancer	7.76e-05	0.00229	CcSEcCtD
Trisalicylate-choline—PTGS2—hindlimb—bone cancer	7.26e-05	0.149	CbGeAlD
Trisalicylate-choline—PTGS2—cartilage tissue—bone cancer	7.15e-05	0.147	CbGeAlD
Trisalicylate-choline—PTGS2—appendage—bone cancer	6.23e-05	0.128	CbGeAlD
Trisalicylate-choline—PTGS1—connective tissue—bone cancer	1.86e-05	0.0382	CbGeAlD
Trisalicylate-choline—PTGS2—connective tissue—bone cancer	1.78e-05	0.0365	CbGeAlD
Trisalicylate-choline—PTGS1—tendon—bone cancer	1.28e-05	0.0263	CbGeAlD
Trisalicylate-choline—PTGS1—spinal cord—bone cancer	1.23e-05	0.0253	CbGeAlD
Trisalicylate-choline—PTGS2—tendon—bone cancer	1.22e-05	0.0251	CbGeAlD
Trisalicylate-choline—PTGS2—bone marrow—bone cancer	1.18e-05	0.0243	CbGeAlD
Trisalicylate-choline—PTGS2—spinal cord—bone cancer	1.18e-05	0.0242	CbGeAlD
